Published in Urol Res on July 22, 2010
Biomolecular mechanism of urinary stone formation involving osteopontin. Urol Res (2012) 0.81
The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells. Urol Res (2011) 0.78
Immunohistochemical localization and mRNA quantification of osteopontin and Tamm-Horsfall protein in canine renal tissue after potassium oxalate injection. BMC Vet Res (2014) 0.75
Osteopontin: a protein with diverse functions. FASEB J (1993) 3.93
Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin. Biochem Biophys Res Commun (2001) 3.46
Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization. Proc Natl Acad Sci U S A (1985) 3.06
Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89
Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol (2000) 2.24
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Modulators of urinary stone formation. Front Biosci (2004) 2.05
Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J (1994) 2.04
Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell (1992) 2.00
Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci U S A (1992) 1.86
Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int (2005) 1.75
Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem (1992) 1.74
Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J (2005) 1.69
Molecular modulation of calcium oxalate crystallization by osteopontin and citrate. Proc Natl Acad Sci U S A (2004) 1.64
Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin. Biochim Biophys Acta (1989) 1.33
Probing crystallization of calcium oxalate monohydrate and the role of macromolecule additives with in situ atomic force microscopy. Langmuir (2004) 1.28
Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol (1989) 1.23
Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium. Am J Kidney Dis (1999) 1.20
On how proteins interact with crystals and their effect on crystal formation. Z Kardiol (2001) 1.18
Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res (1995) 1.17
Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int (1998) 1.15
Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int (1998) 1.15
Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide. J Am Chem Soc (2007) 1.12
Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms. J Cell Biochem (2000) 1.12
Acidic macromolecules of mineralized tissues: the controllers of crystal formation. Trends Biochem Sci (1991) 1.11
Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J (2008) 1.08
Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol (1995) 1.07
Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium. Am J Kidney Dis (2000) 1.02
Osteopontin and calcium stone formation. Nephron Physiol (2004) 1.01
Osteopontin and related phosphorylated sialoproteins: effects on mineralization. Ann N Y Acad Sci (1995) 1.00
Osteopontin in urinary stone formation. Ann N Y Acad Sci (1995) 1.00
Macromolecules and urolithiasis: parallels and paradoxes. Nephron Physiol (2004) 0.99
Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation. Am J Physiol Renal Physiol (2008) 0.99
Modulation of calcium oxalate crystallization by linear aspartic acid-rich peptides. Langmuir (2006) 0.98
Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization. J Phys Chem B (2008) 0.97
Modulation of calcium oxalate dihydrate growth by selective crystal-face binding of phosphorylated osteopontin and polyaspartate peptide showing occlusion by sectoral (compositional) zoning. J Biol Chem (2009) 0.96
Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol (2001) 0.94
Material-tissue interfaces: the role of surface properties and processes. Environ Health Perspect (1994) 0.94
Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells. J Urol (2003) 0.93
Cytokine production induced by binding and processing of calcium oxalate crystals in cultured macrophages. Am J Kidney Dis (2001) 0.91
Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol (2005) 0.91
The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res (1992) 0.91
Urinary crystals and their relation to stone formation. Nature (1967) 0.91
The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals. Urol Res (2007) 0.89
Specific adsorption of osteopontin and synthetic polypeptides to calcium oxalate monohydrate crystals. Biophys J (2007) 0.88
Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res (2003) 0.87
Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals. BJU Int (2005) 0.86
Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin Chem (1991) 0.86
Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation. J Struct Biol (2001) 0.85
Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol (2007) 0.85
Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int (2008) 0.84
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions. Langmuir (2009) 0.84
Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs (2008) 0.84
The hole truth: intracrystalline proteins and calcium oxalate kidney stones. Mol Urol (2000) 0.83
Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid. Scanning Microsc (1996) 0.83
Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones. J Cell Biochem (1996) 0.83
The effects of intracrystalline and surface-bound proteins on the attachment of calcium oxalate monohydrate crystals to renal cells in undiluted human urine. BJU Int (2009) 0.83
Calcium oxalate crystalluria: crystal size in urine. J Urol (1980) 0.82
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Calcif Tissue Int (2009) 0.81
Quantitative studies of human urinary excretion of uropontin. Kidney Int (1998) 0.81
Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis. Am J Physiol Renal Physiol (2007) 0.80
Phosphorylation of osteopontin peptides mediates adsorption to and incorporation into calcium oxalate crystals. Cells Tissues Organs (2008) 0.80
Methods for measuring crystallization in urolithiasis research: why, how and when? Eur Urol (2001) 0.79
Ultrastructural osteopontin localization in papillary stones induced in rats. Eur Urol (1997) 0.79
High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay. Urol Res (2008) 0.79
The roles of autophosphorylation and phosphorylation in the life of osteopontin. Bioessays (1994) 0.78
Effects of microgravity on urinary osteopontin. J Am Soc Nephrol (1999) 0.78
Intracrystalline proteins and calcium oxalate crystal degradation in MDCK II cells. J Struct Biol (2005) 0.78
Distribution of osteopontin and calprotectin as matrix protein in calcium-containing stone. Urol Res (1999) 0.76
Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity. J Biol Chem (2007) 2.03
A novel disulphide switch mechanism in Ero1alpha balances ER oxidation in human cells. EMBO J (2008) 1.97
Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications. Biochem J (2005) 1.69
Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-α and prevents early alcohol-induced liver injury in mice. Hepatology (2014) 1.62
Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. Blood (2009) 1.53
Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J Biol Chem (2007) 1.36
Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem (2010) 1.20
Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J (2008) 1.08
Distinguishing of Ile/Leu amino acid residues in the PP3 protein by (hot) electron capture dissociation in Fourier transform ion cyclotron resonance mass spectrometry. Anal Chem (2003) 1.07
Functional organization of the sortilin Vps10p domain. J Biol Chem (2004) 1.05
Complete characterization of posttranslational modification sites in the bovine milk protein PP3 by tandem mass spectrometry with electron capture dissociation as the last stage. Anal Chem (2003) 1.05
Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol (2009) 1.04
Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol (2003) 1.03
Milk osteopontin, a nutritional approach to prevent alcohol-induced liver injury. Am J Physiol Gastrointest Liver Physiol (2013) 0.96
Role of calcium phosphate nanoclusters in the control of calcification. FEBS J (2009) 0.94
Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest (2009) 0.93
Proteomic analysis of proteins selectively associated with hydroxyapatite, brushite, and uric acid crystals precipitated from human urine. J Proteome Res (2010) 0.91
C-terminal modification of osteopontin inhibits interaction with the αVβ3-integrin. J Biol Chem (2011) 0.89
Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res (2003) 0.87
A comparison of the binding of urinary calcium oxalate monohydrate and dihydrate crystals to human kidney cells in urine. BJU Int (2010) 0.85
Revisiting the structure of the Vps10 domain of human sortilin and its interaction with neurotensin. Protein Sci (2014) 0.85
Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol (2007) 0.85
Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals. BJU Int (2008) 0.84
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions. Langmuir (2009) 0.84
Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs (2008) 0.84
Temperature-controlled encapsulation and release of an active enzyme in the cavity of a self-assembled DNA nanocage. ACS Nano (2013) 0.84
Cooperation of phosphates and carboxylates controls calcium oxalate crystallization in ultrafiltered urine. Urol Res (2011) 0.83
The effects of intracrystalline and surface-bound proteins on the attachment of calcium oxalate monohydrate crystals to renal cells in undiluted human urine. BJU Int (2009) 0.83
Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev (2005) 0.82
Post-translational modification of osteopontin: effects on in vitro hydroxyapatite formation and growth. Biochem Biophys Res Commun (2012) 0.82
Large area protein patterning reveals nanoscale control of focal adhesion development. Nano Lett (2010) 0.82
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy. Calcif Tissue Int (2009) 0.81
Comparison of the specific incorporation of intracrystalline proteins into urinary calcium oxalate monohydrate and dihydrate crystals. J Proteome Res (2010) 0.81
Sialic acid-containing milk proteins show differential immunomodulatory activities independent of sialic acid. J Agric Food Chem (2005) 0.80
Effect of urine fractionation on attachment of calcium oxalate crystals to renal epithelial cells: implications for studying renal calculogenesis. Am J Physiol Renal Physiol (2007) 0.80
ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity. J Biol Chem (2013) 0.79
Comment on epitaxial relationships between uric acid crystals and mineral surfaces: a factor in urinary stone formation. Langmuir (2005) 0.79
Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity. Clin Sci (Lond) (2002) 0.79
4-(Aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole is not specific for labeling of sulfhydryl groups in proteins as it may also react with phenolic hydroxyl groups and amino groups. Anal Biochem (2003) 0.78
The effect of intracrystalline and surface-bound osteopontin on the degradation and dissolution of calcium oxalate dihydrate crystals in MDCKII cells. Urol Res (2011) 0.78
Human GlyCAM-1 mRNA is expressed in the mammary gland as splicing variants and encodes various aberrant truncated proteins. Immunol Lett (2002) 0.77
Osteopontin presentation affects cell adhesion-Influence of underlying surface chemistry and nanopatterning of osteopontin. J Biomed Mater Res A (2010) 0.77
Proteolysis and partial dissolution of calcium oxalate: a comparative, morphological study of urinary crystals from black and white subjects. Urol Res (2005) 0.76
Osteoclasts resorb protein-free mineral (Osteologic discs) efficiently in the absence of osteopontin. In Vivo (2005) 0.76
Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding. Nanotechnology (2017) 0.75
Allopurinol for stones: right drug--wrong reasons. Am J Med (2007) 0.75
Adsorption and enzymatic cleavage of osteopontin at interfaces with different surface chemistries. Biointerphases (2009) 0.75